TrialCancer medicine2018

A phase 4 study of nilotinib in Korean patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTKorea.

Junghoon Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.